Pleural mesothelioma surveillance: Validity of cases from a tumour registry

Canadian Respiratory Journal

Volumn 19, Issue 2, 2012, Pages 103-108

  Labrec̀he, France ^a   Case, BruceW ^b   Ostiguy, Gaston ^c,d   Chalaoui, Jean ^a,e   Camus, Michel ^a,f   Siemiatycki, Jack ^a,e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f HEALTH CANADA   (Canada)

Author keywords

Asbestos related lung disease; Medical chart review; Pleural mesothelioma; Surveillance

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; DIAGNOSTIC IMAGING; FEMALE; HOSPITAL ADMINISTRATOR; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL SPECIALIST; PATHOLOGIST; PHYSICIAN; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RADIOLOGIST; VALIDITY;

EID: 84861312266     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/650935     Document Type: Article

References (23)

1. Lacourt A, Rolland P, Gramond C, et al. Attributable risk in men in two French case-control studies on mesothelioma and asbestos. Eur J Epidemiol 2010;25:799-806.
2. Rushton L, Bagga S, Bevan R, et al. Occupation and cancer in Britain. Brit J Cancer 2010;102:1428-37.
3. Cree M, Lalji M, Jiang B, Carriere KC, Beach J, Kamruzzaman A. Explaining Alberta's rising mesothelioma rates. Chronic Dis Can 2009;29:144-52.
4. Montanaro F, Bray F, Gennaro V, et al. Pleural mesothelioma incidence in Europe: Evidence of some deceleration in the increasing trends. Cancer Causes Control 2003;14:791-803. (Pubitemid 37463893)
5. Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data for 1973 through 2005. Crit Rev Toxicol 2009;39:576-88.
6. Pukkala E, Martinsen JI, Lynge E, et al. Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol 2009;48:646-790.
7. Hannaford-Turner K, Elder D, Sim MR, Abramson MJ, Johnson AR, Yates DH. Surveillance of Australian workplace Based Respiratory Events (SABRE) in New South Wales. Occup Med 2010;60:376-82.
8. Le Stang N, Belot A, Gilg Soit Ilg A, et al. Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005. Int J Cancer 2010;126:232-8.
9. Kirkham TL, Koehoorn MW, McLeod CB, Demers PA. Surveillance of mesothelioma and workers' compensation in British Columbia, Canada. Occup Environ Med 2011;68:30-5.
10. Cree M, Lalji M, Jiang B, Carriere KC. Under-reporting of compensable mesothelioma in Alberta. Am J Ind Med 2009;52:526-33.
11. Payne JI, Pichora E. Filing for workers' compensation among Ontario cases of mesothelioma. Can Respir J 2009;16:148-52.
12. Husain AN, Colby TV, Ordóñez NG, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2009;133:1317-31.
13. Gilg Soit Ilg A, Goldberg M, Rolland P, et al. Programme national de surveillance du mésothéliome - Principaux résultats 1998-2006. Saint-Maurice (Fra) : Institut de veille sanitaire, 2009. 〈www.invs. sante.fr/publications/2009/pnsm/pnsm-resultats-1998-2006. pdf〉 (Accessed June 4, 2011).
14. Safe Work Australia. Mesothelioma in Australia. Incidence 1982 to 2006. Mortality 1997 to 2007. Safe Work Australia, Commonwealth of Australia, 2010. 〈www.safeworkaustralia.gov.au/AboutSafeWorkAustralia/WhatWeDo/Publications/ Documents/339/MesotheliomaInAustralia-Incidence1982-2006-Mortality1997-2007-PDF. pdf〉 (Accessed June 4, 2011).
15. Ferguson DA, Berry G, Jelihovsky T, et al. The Australian mesothelioma surveillance program 1979-1985. Med J Austr 1987;147:166-72. (Pubitemid 18047063)
16. Bignon J, Sebastien P, Di Menza L, Payan H. French mesothelioma register. Ann N Y Acad Sci 1979;330:455-66. (Pubitemid 11223575)
17. Greenberg M, Davies TAL. Mesothelioma register 1967-68. Br J Ind Med 1974;31:91-104.
18. Andrion A, Magnani C, Betta PG, et al. Malignant mesothelioma of the pleura: Interobserver variability. J Clin Pathol 1995;48:856-60.
19. Spirtas R, Keehn RJ, Beebe GW, et al. Results of a pathology review of recent US mesothelioma cases. Accomplishments Oncol 1986;1:144-52.
20. Geoffroy-Perez B. Confrontation des données du Programme national de surveillance du mésothéliome et du PMSI. Rapport d'tude, Institut de veille sanitaire, France, 2004. 〈www.invs.sante.fr/ publications/2004/surveillance-mesotheliome/rapport-mesotheliome-pmsi.pdf〉 (Accessed June 4, 2011).
21. De Guire L, Provencher S. Étude des nouveaux cas de maladies professionnelles pulmonaires reliées à l'exposition à l'amiante au Québec : 1988-2003. Direction des Risques biologiques, environnementaux et occupationnels, Institut national de santépublique du Québec, Montréal, 2009. 〈www.inspq.qc.ca/pdf/publications/ 968-MalPulmoAmianteQc1988-2003.pdf〉 (Accessed June 4, 2011).
22. Lebel G, Gingras S. De Guire L. Jumelage des cas de mésothé liome et d'amiantose reconnus comme maladies professionnelles pulmonaires aux nouveaux cas de cancer et aux hospitalisations avec amiantose. Direction des Risques biologiques, environnementaux et occupationnels, Institut national de santé publique du Québec, Montréal, 2009. 〈www.inspq.qc.ca/pdf/publications/1002-JumelageMesoAmian.pdf〉 (Accessed June 4, 2011).
23. British Thoracic Society Standards of Care Committee. BTS statement on malignant mesothelioma in the UK, 2007. Thorax 2007;62(Suppl 2):ii1-19.